By Josh BeckermanShares of dental-laser company Biolase were recently down 41%, to 8 cents, with the stock hitting a 52-week low of 7 cents Wednesday, following the pricing of a $4.5 million offering of units. The 52-week high of $5.94 took place on Aug. 12.

Source: Wall Street Journal May 24, 2023 18:16 UTC